Biora Therapeutics Inc Cash Flow Quality Index

Latest as of September 2024: -0.10x

Biora Therapeutics Inc cash flow quality index. Biora Therapeutics Inc (BIOR) has a Cash Flow Quality Index of -0.10x as of September 2024. Operating cash flow of $-8.73 Million is below net income of $90.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Biora Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.10x
Operating CF / Net Income

Operating Cash Flow

$-8.73 Million
USD

Net Income

$90.56 Million
USD

Data as of

Sep 2024
Most recent filing

Biora Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Biora Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Biora Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Biora Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.